rosiglitazone has been researched along with Liver Failure in 12 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 12 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barbehenn, E; Floyd, JS; Lurie, P; Wolfe, SM | 1 |
Cobitz, AR; Kolatkar, NS; Koro, CE; Osei, SY; Stender, M | 1 |
Beiderbeck, AB; Sakaguchi, M | 1 |
Iyer, S; Perez, A; Rajagopalan, R | 1 |
Lai, MY; Su, DH; Wu, HP | 1 |
Diamond, RH; Forman, LM; Simmons, DA | 1 |
Boscia, J; Everitt, D; Freid, J | 1 |
Isley, WL; Oki, JC | 1 |
Gale, EA | 1 |
McMorran, M; Vu, D | 1 |
Cohen, RI; Gouda, HE; Khan, A; Schwartz, J | 1 |
Freed, MI; Kreider, M; Lebovitz, HE | 1 |
1 review(s) available for rosiglitazone and Liver Failure
Article | Year |
---|---|
Lessons from the glitazones: a story of drug development.
Topics: Adverse Drug Reaction Reporting Systems; Chemical and Drug Induced Liver Injury; Chromans; Diabetes Mellitus, Type 2; Drug Approval; Drug Therapy, Combination; Europe; Humans; Hypoglycemic Agents; Liver Failure; Pioglitazone; Rosiglitazone; Thiazoles; Thiazolidinediones; Troglitazone; United States | 2001 |
1 trial(s) available for rosiglitazone and Liver Failure
Article | Year |
---|---|
Evaluation of liver function in type 2 diabetic patients during clinical trials: evidence that rosiglitazone does not cause hepatic dysfunction.
Topics: Adult; Aged; Aged, 80 and over; Alanine Transaminase; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Humans; Hypoglycemic Agents; Liver Failure; Liver Function Tests; Male; Metformin; Middle Aged; Reference Values; Rosiglitazone; Thiazoles; Thiazolidinediones | 2002 |
10 other study(ies) available for rosiglitazone and Liver Failure
Article | Year |
---|---|
Case series of liver failure associated with rosiglitazone and pioglitazone.
Topics: Adverse Drug Reaction Reporting Systems; Aged; Chemical and Drug Induced Liver Injury; Databases, Factual; Diabetes Mellitus, Type 2; Female; Humans; Hypoglycemic Agents; Liver Failure; Male; Middle Aged; Pioglitazone; Risk Factors; Rosiglitazone; Thiazolidinediones; Time Factors | 2009 |
Commentary on 'Case series of liver failure associated with rosiglitazone and pioglitazone' by Floyd et al.
Topics: Adverse Drug Reaction Reporting Systems; Chemical and Drug Induced Liver Injury; Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; Liver Failure; Pioglitazone; Rosiglitazone; Thiazolidinediones | 2009 |
Commentary on 'Case series of liver failure associated with rosiglitazone and pioglitazone' by James Floyd et al.
Topics: Adverse Drug Reaction Reporting Systems; Chemical and Drug Induced Liver Injury; Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; Liver Failure; Pioglitazone; Rosiglitazone; Thiazolidinediones | 2009 |
Comparison of pioglitazone with other antidiabetic drugs for associated incidence of liver failure: no evidence of increased risk of liver failure with pioglitazone.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Chemical and Drug Induced Liver Injury; Female; Humans; Hypoglycemic Agents; Liver Failure; Male; Metformin; Middle Aged; Pioglitazone; Retrospective Studies; Risk Factors; Rosiglitazone; Sulfonylurea Compounds; Thiazolidinediones | 2005 |
Liver failure in a patient receiving rosiglitazone therapy.
Topics: Diabetes Mellitus; Female; Humans; Hypoglycemic Agents; Liver Failure; Liver Function Tests; Middle Aged; Rosiglitazone; Thiazolidinediones | 2006 |
Hepatic failure in a patient taking rosiglitazone.
Topics: Aged; Combined Modality Therapy; Coronary Disease; Diabetes Mellitus, Type 2; Drug Interactions; Humans; Hypoglycemic Agents; Ischemia; Liver; Liver Failure; Male; Monitoring, Physiologic; Pravastatin; Rosiglitazone; Thiazoles; Thiazolidinediones; Verapamil | 2000 |
Rosiglitazone and hepatic failure.
Topics: Coronary Disease; Humans; Hypoglycemic Agents; Ischemia; Liver; Liver Failure; Rosiglitazone; Thiazoles; Thiazolidinediones | 2000 |
Rosiglitazone and liver failure.
Topics: Humans; Liver Failure; Rosiglitazone; Thiazoles; Thiazolidinediones | 2000 |
Rosiglitazone (Avandia): hepatic, cardiac and hematological reactions.
Topics: Aged; Cardiovascular Diseases; Chemical and Drug Induced Liver Injury; Female; Hematologic Diseases; Humans; Hypoglycemic Agents; Liver Failure; Male; Middle Aged; Rosiglitazone; Thiazoles; Thiazolidinediones | 2001 |
Liver failure in a patient treated with long-term rosiglitazone therapy.
Topics: Aged; Aged, 80 and over; Chemical and Drug Induced Liver Injury; Humans; Hypoglycemic Agents; Liver Failure; Male; Rosiglitazone; Thiazoles; Thiazolidinediones | 2001 |